Hikma Pharmaceutical | HIK - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $15M in Net Income for its fiscal semester ending in December of 2022.


Net Income Change
Almirall SA ALM:SM EUR -23054000 50.39M
Artemis Alpha ATS:LN GBP -16638000 10.13M
AstraZeneca AZN:LN USD 1.8B 902M
Bayer BAYN:GR EUR 2.18B 1.57B
Fresenius FRE:GR EUR 346M 91M
Galapagos GLPG:NA EUR 23.21M 230.41M
Genmab GEN:DC DKK 226M 358M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
Hikma Pharmaceutical HIK:LN USD 15M 158M
Lonza Group LONN:SW CHF 723M 231M
Merck MRK:GR EUR 796M 142M
Orion ORNBV:FH EUR 43.8M 12.1M
Recordati REC:IM EUR 123.95M 53.08M
Roche Holding ROG:VX 3.89B 4.64B
UCB UCB:BB 19M 380M